Conditional coupling of striatal dopamine D1 receptor to transcription factors: Ontogenic and regional differences in CREB activation

Molecular Brain Research

Volumn 60, Issue 1, 1998, Pages 127-132

  Arnauld, Elisabeth ^a   Arsaut, Josette ^a   Demotes Mainard, Jacques ^a  

^a INSERM   (France)

Author keywords

Brain development; c fos; Caudal striatum; Dopamine D1 receptor; Gene expression; Striatal compartment

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; CYCLIC AMP RESPONSIVE ELEMENT BINDING PROTEIN; DOPAMINE 1 RECEPTOR; TRANSCRIPTION FACTOR;

ANIMAL EXPERIMENT; ARTICLE; CORPUS STRIATUM; IMMUNOCYTOCHEMISTRY; MALE; MOUSE; NONHUMAN; ONCOGENE C FOS; ONTOGENY; PERINATAL PERIOD; PRIORITY JOURNAL;

2,3,4,5-TETRAHYDRO-7,8-DIHYDROXY-1-PHENYL-1H-3-BENZAZEPINE; AGE FACTORS; ANIMALS; ANIMALS, NEWBORN; CORPUS STRIATUM; CYCLIC AMP RESPONSE ELEMENT-BINDING PROTEIN; DOPAMINE AGONISTS; GENE EXPRESSION REGULATION, DEVELOPMENTAL; MALE; MICE; PROTO-ONCOGENE PROTEINS C-FOS; RECEPTORS, DOPAMINE D1; TRANS-ACTIVATION (GENETICS);

EID: 0032544701     PISSN: 0169328X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-328X(98)00192-2     Document Type: Article

References (42)

1. Arnauld E., Arsaut J., Demotes-Mainard J. Functional heterogeneity of the caudate-putamen as revealed by c-fos induction in response to D1 receptor activation. Mol. Brain Res. 18:1993;339-342.
2. Arnauld E., Arsaut J., Tafani J.-A.M., Demotes-Mainard J. Dopaminergic control of gene transcription during striatal ontogeny: c-fos induction by D1 receptor activation in the developing striosomes. Mol. Brain Res. 30:1995;223-232.
3. Arnauld E., Jeantet Y., Arsaut J., Demotes-Mainard J. Involvement of the caudal striatum in auditory processing: c-fos response to cortical application of picrotoxin and to auditory stimulation. Mol. Brain Res. 41:1996;27-35.
4. Bradford M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72:1976;248-254.
5. Bravo R., Neuberg M., Burckhardt J., Amlendral J., Wallich R., Muller R. Involvement of common and cell type-specific pathways of c-fos gene control: stable induction by cAMP in macrophages. Cell. 48:1987;251-260.
6. Cole D.G., Kobierski L.A., Konradi C., Hyman S.E. 6-Hydroxydopamine lesions of the rat substantia nigra up-regulate dopamine-induced phosphorylation of the cAMP-response element-binding protein in striatal neurons. Proc. Natl. Acad. Sci. USA. 91:1994;9631-9635.
7. Cole R.L., Konradi C., Douglass J., Hyman S.E. Neuronal adaptation to amphetamine and dopamine: molecular mechanisms of prodynorphin gene regulation in rat striatum. Neuron. 14:1995;813-823.
8. Dragunow M., Robertson G.S., Faull R.L.M., Robertson H.A., Jansen K. D2 dopamine receptor antagonists induce Fos and related proteins in rat striatal neurons. Neuroscience. 37:1990;287-294.
9. Edwards D.R. Cell signalling and the control of gene transcription. Trends Pharmacol. Sci. 15:1994;239-244.
10. Gerfen C.R., Engber T.M., Mahan L.C., Susel Z., Chase T.N., Monsma F.J., Sibley D.R. D1 and D2 dopamine receptor-regulated gene expression in striatonigral and striopallidal neurons. Science. 250:1990;1429-1432.
11. Gerfen C.R. The neostriatal mosaic: multiple levels of compartmental organisation. Trends Neurosci. 15:1992;133-138.
12. Ginty D.D., Kornhauser J.M., Thompson M.A., Bading H., Mayo K.E., Takahashi J.S., Greenberg M.E. Regulation of CREB phosphorylation in the suprachasmatic nucleus by light and circadian clock. Science. 260:1993;238-241.
13. Graybiel A.M., Moratalla R., Robertson H.A. Amphetamine and cocaine induce drug specific activation of the c-fos gene in striosome matrix compartments and limbic subdivisions of the striatum. Proc. Natl. Acad. Sci. USA. 87:1990;6912-6916.
14. Guennoun R., Bloch B. Ontogeny of D1 and DARPP-32 gene expression in the rat striatum: an in situ hybridization study. Mol. Brain Res. 12:1992;131-139.
15. Hemmings H.C. Jr., Greengard P., Tung H.Y.L., Cohen P. DARPP-32, a dopamine-regulated neuronal phosphoprotein, is a potent inhibitor of protein phosphatase-1. Nature. 310:1984;503-505.
16. Hill C.S., Treisman R. Transcription regulation by extracellular signals: mechanisms and specificity. Cell. 80:1995;199-211.
17. Hope B.T., Kosofsky B.E., Hyman S.E., Nestler E.J. Regulation of immediate early gene expression and AP-1 binding in the rat nucleus accumbens by chronic cocaine. Proc. Natl. Acad. Sci. USA. 89:1992;5764-5768.
18. Hunter T., Karin M. The regulation of transcription by phosphorylation. Cell. 70:1992;375-387.
19. Hunter T. Protein kinases and phosphatases: the Yin and Yang of protein phosphorylation and signalling. Cell. 80:1995;225-236.
20. Joyce J.N., Frohna P.A., Neal-Beliveau B.S. Functional and molecular differentiation of the dopamine system induced by neonatal denervation. Neurosci. Biobehav. Rev. 20:1996;453-486.
21. Jung A.B., Bennett J.P. Jr. Development of striatal dopaminergic function. II: Dopaminergic regulation of transcription of the immediate early gene zif 268 and of D1 (D1a) and D2 (D2a) receptors during pre- and postnatal development. Dev. Brain Res. 94:1996;121-132.
22. Kosofsky B.E., Genova L.M., Hyman S.E. Postnatal age defines specificity of immediate early genes induction by cocaine in developing rat brain. J. Comp. Neurol. 351:1995;27-40.
23. Le Moine C., Normand E., Bloch B. Phenotypical characterization of the rat striatal neurons expressing the D1 dopamine receptor gene. Proc. Natl. Acad. Sci. USA. 88:1991;4205-4209.
24. Levy R., Vila M., Herrero M.-T., Faucheux B., Agid Y., Hirsch E.C. Striatal expression of substance P and methionin-enkephalin genes in patients with Parkinson's disease. Neurosci. Lett. 199:1995;220-224.
25. Liu F.C., Graybiel A.M. Spatiotemporal dynamics of CREB phosphorylation: transient versus sustained phosphorylation in the developing striatum. Neuron. 17:1996;1133-1144.
26. Merchant K.M., Dorsa D.M. Differential induction of neurotensin and c-fos gene expression by typical versus atypical antipsychotics. Proc. Natl. Acad. Sci. USA. 90:1993;3447-3451.
27. Nguyen T.V., Kosofsky B.E., Birnbaum R., Cohen B.M., Hyman S.E. Differential expression of c-Fos and Zif268 in rat striatum after haloperidol, clozapine and amphetamine. Proc. Natl. Acad. Sci. USA. 89:1992;4270-4274.
28. Rao P.A., Molinoff P.B., Joyce J.N. Ontogeny of dopamine D1 and D2 receptor subtypes in rat basal ganglia: a quantitative autoradiographic study. Dev. Brain Res. 60:1991;161-177.
29. Robertson G.S., Herrera D.G., Dragunow M., Robertson H.A. L-DOPA activates c-fos in the striatum ipsilateral to a 6-hydroxydopamine lesion of the substantia nigra. Eur. J. Pharmacol. 159:1989;99-100.
30. Robertson G.S., Vincent S.R., Fibiger H.C. Striatonigral projection neurons contain D1 dopamine receptor-activated c-fos. Brain Res. 523:1990;288-290.
31. Robertson G.S., Fibiger H.C. Neuroleptics increase c-fos expression in the forebrain: contrasting effects of haloperidol and clozapine. Neuroscience. 46:1992;315-328.
32. Robertson G.S., Vincent S.R., Fibiger H.C. D1 and D2 dopamine receptors differentially regulate c-fos expression in striatonigral and striatopallidal neurons. Neuroscience. 49:1992;285-296.
33. Robertson H.A., Peterson M.R., Murphy K., Robertson G.S. D1 dopamine receptor agonists selectively activate striatal c-fos independent of rotational behavior. Brain Res. 503:1989;346-349.
34. Schiffmann S.N., Lledo P.M., Vincent J.D. Dopamine D1 receptor modulates the voltage-gated sodium current in rat striatal neurones through a protein kinase A. J. Physiol. 483:1995;95-107.
35. Shu S., Ju G., Fan L. The glucose-oxidase-DAB-nickel method in peroxidase histochemistry of the nervous system. Neurosci. Lett. 85:1988;169-171.
36. Surmeier D.J., Bargas J., Hemmings H.C. Jr., Nairn A.C., Greengard P. Modulation of calcium currents by a D1 dopaminergic protein kinase/phosphatase cascade in rat neostriatal neurons. Neuron. 14:1995;385-397.
37. Van der Kooy D. Early postnatal lesions of the substantia nigra produces massive shrinkage of the rat striatum, disruption of the patch neuron distribution, but no loss of patch neurons. Dev. Brain Res. 94:1996;242-245.
38. Weaver D.R., Reppert S.M. Definition of the developmental transition from dopaminergic to photic regulation of c-fos gene expression in the rat suprachiasmatic nucleus. Mol. Brain Res. 33:1995;136-148.
39. Xing J., Ginty D.D., Greenberg M.E. Coupling of the RAS-MAPK pathway to gene activation by RSK2, a growth factor-regulated CREB kinase. Science. 273:1996;959-963.
40. Xu M., Moratalla R., Gold L.H., Hiroi N., Koob G.F., Graybiel A.M., Tonegawa S. Dopamine D1 receptor mutant mice are deficient in striatal expression of dynorphin and in dopamine-mediated behavioral responses. Cell. 79:1994;729-742.
41. Young S.T., Porrino L.J., Iadarola M.J. Cocaine induces striatal c-Fos-immunoreactive proteins via dopaminergic D1 receptors. Proc. Natl. Acad. Sci. USA. 88:1991;1291-1295.
42. Young W.S. III, Bonner T.I., Brann M.R. Mesencephalic dopamine neurons regulate the expression of neuropeptide mRNAs in the rat forebrain. Proc. Natl. Acad. Sci. USA. 83:1986;9827-9831.